Crossmark

Modelling human liver disease: from steatotic liver disease to MASH-HCC

Published Online: 2024-10-24

Published Print: 2025-01

Authors

Stoess, Christian

Feldstein, Ariel E.
License Information

Text and Data Mining valid from 2024-10-24

Version of Record valid from 2024-10-24
More Information

Article History

First Online: 24 October 2024

Competing interests

: A.E.F. is an employee and stockholder of Novo Nordisk. C.S. declares no competing interests.

Document is current